Virtus ETF Advisers
TNDM icon

Virtus ETF Advisers’s Tandem Diabetes Care TNDM Stock Holding History

Virtus ETF Advisers’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-4,511
Closed -$68.1K – 555
2026
Q2 		$68.1K Buy
4,511
+111
+3% +$1.94K 0.03% 390
2026
Q1 		$84.3K Buy
+4,400
New +$95.6K 0.04% 348

Other funds holding TNDM

GW&K Investment Management
GW&K Investment Management Boston, Massachusetts $11.8B AUM 29.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Paradice Investment Management
Paradice Investment Management Denver, Colorado $594M AUM 28.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Royce & Associates
Royce & Associates New York $11B AUM 39.4% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Jefferies Financial Group
Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Virtus ETF Advisers's TNDM Position: Q3 2026 in Review

Virtus ETF Advisers sold out of Tandem Diabetes Care (TNDM) in Q3 2026, closing a stake of 4,511 shares — an estimated $68.1K sold.

Virtus ETF Advisers first reported a position in TNDM in Q1 2026 and held it in 2 quarters. The position peaked at $84.3K in Q1 2026. 137 funds tracked by Wall St. Rank hold TNDM as of Q3 2026.

  • Virtus ETF Advisers reported no remaining Tandem Diabetes Care position as of Q3 2026 after selling out during the quarter.
  • Virtus ETF Advisers sold 4,511 Tandem Diabetes Care shares in Q3 2026, an estimated $68.1K.
  • Virtus ETF Advisers first reported a position in Tandem Diabetes Care in Q1 2026 and held it in 2 quarters.
  • Virtus ETF Advisers's Tandem Diabetes Care position peaked at $84.3K in Q1 2026.
  • 137 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2026.

Based on Virtus ETF Advisers's 13F filing for Q3 2026, filed 9 Nov 2026.